K
Kishore V. L. Parsa
Researcher at University of Hyderabad
Publications - 73
Citations - 1798
Kishore V. L. Parsa is an academic researcher from University of Hyderabad. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 21, co-authored 62 publications receiving 1600 citations. Previous affiliations of Kishore V. L. Parsa include Texas A&M University–Kingsville & Ohio State University.
Papers
More filters
Journal ArticleDOI
Use of polyethyleneimine polymer in cell culture as attachment factor and lipofection enhancer
Ajith R. Vancha,Suman Govindaraju,Kishore V. L. Parsa,Madhuri Jasti,Maribel González-García,Rafael P. Ballestero +5 more
TL;DR: Polyethyleneimine is an effective attachment factor for weakly anchoring cell lines and primary cells and increases the yield of expressed products with commonly used cell lines such as PC-12 and HEK-293 cells.
Journal ArticleDOI
Pulmonary Surfactant Protein A Regulates TLR Expression and Activity in Human Macrophages
Lisa Novik Henning,Abul K. Azad,Kishore V. L. Parsa,Joy E. Crowther,Susheela Tridandapani,Larry S. Schlesinger +5 more
TL;DR: A critical role is identified for SP-A in modulating the lung inflammatory response by regulating macrophage TLR activity during the differentiation of primary human monocytes into macrophages.
Journal ArticleDOI
Akt/Protein kinase B modulates macrophage inflammatory response to Francisella infection and confers a survival advantage in mice.
Murugesan V. S. Rajaram,Latha P. Ganesan,Kishore V. L. Parsa,Jonathan P. Butchar,John S. Gunn,Susheela Tridandapani +5 more
TL;DR: It is demonstrated that F. novicida infection of murine macrophages induces the activation of Akt, and that Akt activation may be regulated by bacterial genes associated with phagosomal escape, thereby contributing to immunity against F.novicida.
Journal ArticleDOI
A new three-component reaction: green synthesis of novel isoindolo[2,1-a]quinazoline derivatives as potent inhibitors of TNF-α
K. Siva Kumar,K. Siva Kumar,P. Mahesh Kumar,K. Anil Kumar,M. Sreenivasulu,Ahamed A. Jafar,D. Rambabu,G. Rama Krishna,C. Malla Reddy,Ravikumar Kapavarapu,K. Shivakumar,K. Krishna Priya,Kishore V. L. Parsa,Manojit Pal +13 more
TL;DR: Concurrent construction of five and six membered fused N-heretocyclic ring was achieved via a conceptually new three-component reaction affording 6,6a-dihydroisoindolo[2,1-a]quinazoline-5,11-diones as novel inhibitors of TNF-α in vitro.
Journal ArticleDOI
Emerging drug candidates of dipeptidyl peptidase IV (DPP IV) inhibitor class for the treatment of Type 2 Diabetes.
Rajesh Gupta,Sameer S. Walunj,Ranjeet K. Tokala,Kishore V. L. Parsa,Santosh Kumar Singh,Manojit Pal +5 more
TL;DR: The present review summarizes the latest preclinical and clinical trial data of different DPP IV inhibitors with a special emphasis on their DPP8/9 fold selectivity and therapeutic advantages over GLP-1 based approach.